Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

New compound class found to trigger changes in cell garbage can

25.07.2003


Researchers have discovered a novel class of compounds that affects the cell’s garbage disposal system which degrades proteins and opens a window for understanding a vital cell function as well as for treating heart disease and cancer.



The distinctive mechanisms of these compounds are reported in the July 29 issue of Biochemistry and online earlier this month by Dr. Michael Simons, professor of medicine and of pharmacology and toxicology at Dartmouth Medical School and head of cardiology at Dartmouth-Hitchcock Medical Center, with colleagues from Dartmouth and the University of Texas.

Just as cells produce proteins, they must also get rid of those they no longer need. Structures called proteasomes chew up proteins made within the cell -- including viruses and other parasites -- that are targeted for destruction.


Proteasomes are a complex of enzymes with a cylinder core and a lid on the top and bottom. "The proteins come in and are digested like a big garbage can." Simons said. Proteasomes are an attractive target for drug development because manipulating them to prevent or provoke degradation of a particular protein affects most cell activities.

In studying compounds that promote the formation of new blood vessels, (angiogenesis), Simons and his colleagues found these compounds constituted a new class of inhibitor that changes the shape of the proteasome. "This is a completely different class of proteasome inhibitors with unusual mechanisms," Simons said.

Generally, proteasome inhibitors interact with an active site of the protein-digesting enzymes on chains inside the proteasome cylinder. The new-found class, proline/arginine-rich peptides, instead bind to the outside of the proteasome cylinder, triggering it to change shape in a way that limits the proteins they can ingest. The effects appear in all proteasomes, from yeast to humans.

Normal proteasomes look like regular circles; when the researchers add the peptide, the proteasome takes a dumbbell shape. Substances cannot easily get into the proteasome and its activity range is restricted. As a result, it will destroy only a small number of proteins.

"So this is a new mechanism of action, a new class of inhibitors and has interesting therapeutic implications," Simons said.

Since the compounds do not act on the active site of an enzyme, but on its shape, the effects are reversible, meaning that treatment options are controllable. Moreover, there is intriguing therapeutic potential for both heart disease and cancer.

These peptides are especially powerful agents for inducing vessel growth and their angiogenic activity correlates with their ability to interact with certain proteasomes and change their shapes. One result is that they turn off degradation of master switch genes that activate several different angiogenic cascades.

These peptides also prevent degradation of a molecule that normally inhibits activity of nuclear factor kappa B that controls a number of cell processes including growth and inflammation. High levels of the molecule, IkB, impede cell growth, which has implications for use against cancers. Simons speculates that by changing peptide structure, the dual effects of stimulating and stopping growth can be separated.

The findings provide insights into proteasome functions. This peptide appears to regulate how proteasomes interact with the proteins destined for obliteration. Proteasomes are known to change shape when they interact with an inhibitor, but "this is a very unusual shape change; it does not fit any known patterns," Simons added.

Now the researchers are detailing the functions of this naturally occurring immune response peptide . It was originally isolated form pig intestines for use in healing wounds because of its multiple roles as an agent that stimulates vessel growth, inhibits inflammatory responses and kills bacteria.

Coauthors include Mark Post, visiting associate professor of medicine at DMS, as well as M. Maria Gaczynska and Pawel A. Osmulski, of the University of Texas Health Science Center at San Antonio and Youhe Gao of Beijing.

DMS Communications | EurekAlert!
Further information:
http://www.dartmouth.edu

More articles from Life Sciences:

nachricht Topologische Quantenchemie
21.07.2017 | Max-Planck-Institut für Chemische Physik fester Stoffe

nachricht Topological Quantum Chemistry
21.07.2017 | Max-Planck-Institut für Chemische Physik fester Stoffe

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Manipulating Electron Spins Without Loss of Information

Physicists have developed a new technique that uses electrical voltages to control the electron spin on a chip. The newly-developed method provides protection from spin decay, meaning that the contained information can be maintained and transmitted over comparatively large distances, as has been demonstrated by a team from the University of Basel’s Department of Physics and the Swiss Nanoscience Institute. The results have been published in Physical Review X.

For several years, researchers have been trying to use the spin of an electron to store and transmit information. The spin of each electron is always coupled...

Im Focus: The proton precisely weighted

What is the mass of a proton? Scientists from Germany and Japan successfully did an important step towards the most exact knowledge of this fundamental constant. By means of precision measurements on a single proton, they could improve the precision by a factor of three and also correct the existing value.

To determine the mass of a single proton still more accurate – a group of physicists led by Klaus Blaum and Sven Sturm of the Max Planck Institute for Nuclear...

Im Focus: On the way to a biological alternative

A bacterial enzyme enables reactions that open up alternatives to key industrial chemical processes

The research team of Prof. Dr. Oliver Einsle at the University of Freiburg's Institute of Biochemistry has long been exploring the functioning of nitrogenase....

Im Focus: The 1 trillion tonne iceberg

Larsen C Ice Shelf rift finally breaks through

A one trillion tonne iceberg - one of the biggest ever recorded -- has calved away from the Larsen C Ice Shelf in Antarctica, after a rift in the ice,...

Im Focus: Laser-cooled ions contribute to better understanding of friction

Physics supports biology: Researchers from PTB have developed a model system to investigate friction phenomena with atomic precision

Friction: what you want from car brakes, otherwise rather a nuisance. In any case, it is useful to know as precisely as possible how friction phenomena arise –...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

Closing the Sustainability Circle: Protection of Food with Biobased Materials

21.07.2017 | Event News

»We are bringing Additive Manufacturing to SMEs«

19.07.2017 | Event News

The technology with a feel for feelings

12.07.2017 | Event News

 
Latest News

NASA looks to solar eclipse to help understand Earth's energy system

21.07.2017 | Earth Sciences

Stanford researchers develop a new type of soft, growing robot

21.07.2017 | Power and Electrical Engineering

Vortex photons from electrons in circular motion

21.07.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>